We are live on ! Find out more
SNDX icon

Syndax Pharmaceuticals
SNDX

210 hedge funds and large institutions have $1.71B invested in Syndax Pharmaceuticals in 2024 Q3 according to their latest regulatory filings, with 38 funds opening new positions, 86 increasing their positions, 58 reducing their positions, and 24 closing their positions.

New
Increased
Maintained
Reduced
Closed

58% more first-time investments, than exits

New positions opened: 38 | Existing positions closed: 24

48% more repeat investments, than reductions

Existing positions increased: 86 | Existing positions reduced: 58

7% more funds holding

Funds holding: 196 → 210 (+14)

1.76% more ownership

Funds ownership: 102.79% → 104.55% (+1.8%)

9% more call options, than puts

Call options by funds: $16.2M | Put options by funds: $14.9M

4% less capital invested

Capital invested by funds: $1.79B → $1.71B (-$80M)

18% less funds holding in top 10

Funds holding in top 10: 11 → 9 (-2)

Holders
210
Holders Change
+14
Holders Change %
+7.14%
% of All Funds
3.02%
Holding in Top 10
9
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-18.18%
% of All Funds
0.13%
New
38
Increased
86
Reduced
58
Closed
24
Calls
$16.2M
Puts
$14.9M
Net Calls
+$1.27M
Net Calls Change
-$2.89M

Top Buyers

1
BNP Paribas Asset Management
BNP Paribas Asset Management
France
+$16.3M
2
EAM
Eventide Asset Management
Massachusetts
+$16.3M
3
FTM
First Turn Management
California
+$11.3M
4
PCH
Polar Capital Holdings
United Kingdom
+$10.3M
5
EP
Eversept Partners
New York
+$10.2M

Top Sellers

1
Wellington Management Group
Wellington Management Group
Massachusetts
-$48.6M
2
SI
Sofinnova Investments
California
-$28.2M
3
APM
Avidity Partners Management
Texas
-$18.2M
4
Marshall Wace
Marshall Wace
United Kingdom
-$17.4M
5
ECM
ExodusPoint Capital Management
New York
-$6.35M
Name Holding Trade Value Shares
Change 		Change in
Stake
Simplex Trading
151
Simplex Trading
Illinois
$307K +$209K +10,107 +172%
Public Employees Retirement Association of Colorado
152
Public Employees Retirement Association of Colorado
Colorado
$265K – – –
Russell Investments Group
153
Russell Investments Group
United Kingdom
$260K +$4.77K +231 +2%
Zurich Cantonal Bank
154
Zurich Cantonal Bank
Switzerland
$235K -$310 -15 -0.1%
Group One Trading
155
Group One Trading
Illinois
$226K +$195K +9,434 +407%
EFM
156
E Fund Management
China
$212K +$4.42K +214 +2%
PD
157
Point72 (DIFC)
United Arab Emirates
$205K -$1.51K -73 -0.7%
Acadian Asset Management
158
Acadian Asset Management
Massachusetts
$196K +$211K +10,200 New
MFIM
159
Mesirow Financial Investment Management
Illinois
$195K +$209K +10,126 New
Victory Capital Management
160
Victory Capital Management
Texas
$194K -$5.27K -255 -2%
WS
161
Wedbush Securities
California
$193K – – –
FCM
162
Farallon Capital Management
California
$193K – – –
LCAM
163
Long Corridor Asset Management
Hong Kong
$193K +$207K +10,000 New
Royal Bank of Canada
164
Royal Bank of Canada
Ontario, Canada
$181K +$24K +1,162 +14%
ETC
165
Exchange Traded Concepts
Oklahoma
$177K -$8.14K -394 -4%
US Bancorp
166
US Bancorp
Minnesota
$155K +$2.58K +125 +2%
AIP
167
Ameritas Investment Partners
Nebraska
$151K – – –
TRCT
168
Tower Research Capital (TRC)
New York
$125K -$189K -9,146 -58%
ACM
169
Aquatic Capital Management
Illinois
$119K +$128K +6,200 New
SO
170
STRS Ohio
Ohio
$104K -$471K -22,800 -81%
VEA
171
Virtus ETF Advisers
New York
$85.7K +$1.61K +78 +2%
Osaic Holdings
172
Osaic Holdings
Arizona
$74.3K +$6.53K +316 +9%
S
173
SignatureFD
Georgia
$73.6K +$1.84K +89 +2%
KBC Group
174
KBC Group
Belgium
$65K – – –
Mirae Asset Global Investments
175
Mirae Asset Global Investments
South Korea
$58.1K +$11.2K +541 +21%
5 6
7
8 9

SNDX Hedge Fund Activity: Q3 2024 in Review

210 of the 6,964 institutional investors tracked by Wall St. Rank reported a position in Syndax Pharmaceuticals (SNDX) for Q3 2024, worth a combined $1.71B — down 4.5% from $1.79B a quarter earlier.

Buyers outnumbered sellers: 38 funds opened new SNDX positions and 24 closed out — a net gain of 14 holders — while 86 added to existing stakes and 58 trimmed.

The largest buyer was BNP Paribas Asset Management, opening a new position worth an estimated $16.3M. The largest seller was Wellington Management Group, cutting an estimated $48.6M.

  • 210 institutional investors held Syndax Pharmaceuticals (SNDX) as of Q3 2024, up from 196 in Q2 2024.
  • Funds reported $1.71B of Syndax Pharmaceuticals stock for Q3 2024, down 4.5% quarter-over-quarter.
  • 38 funds opened new Syndax Pharmaceuticals positions in Q3 2024 and 24 closed out, a net change of +14 holders.
  • The largest Syndax Pharmaceuticals buyer in Q3 2024 was BNP Paribas Asset Management, an estimated $16.3M added.
  • The largest Syndax Pharmaceuticals seller in Q3 2024 was Wellington Management Group, an estimated $48.6M sold.

Based on aggregated 13F filings for Q3 2024.